These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2924019)

  • 21. [Age and aging in Friedrich Hoffmann's medical practice].
    Schlöder C; Schochow M; Steger F
    Medizinhist J; 2014; 49(3):237-59. PubMed ID: 26035917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Idiotypic network connectivity and a possible cause of myasthenia gravis.
    Dwyer DS; Vakil M; Kearney JF
    J Exp Med; 1986 Oct; 164(4):1310-8. PubMed ID: 2428915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Size and connectivity as emergent properties of a developing immune network.
    de Boer RJ; Perelson AS
    J Theor Biol; 1991 Apr; 149(3):381-424. PubMed ID: 2062103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simple model for the immune network.
    Parisi G
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):429-33. PubMed ID: 2296597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel mechanisms of specific suppression of anti-hapten antibody response mediated by monoclonal anti-carrier antibody.
    Sumida T; Taniguchi M
    J Immunol; 1985 Jun; 134(6):3675-81. PubMed ID: 3157746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiidiotypic immunosuppression and its treatment with human immunoglobulin preparations.
    Nydegger UE; Blaser K; Hässig A
    Vox Sang; 1984; 47(1):92-5. PubMed ID: 6610988
    [No Abstract]   [Full Text] [Related]  

  • 27. Idiotypic regulation of autoantibody production.
    Zanetti M
    Crit Rev Immunol; 1986; 6(2):151-83. PubMed ID: 3089685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of anti-DNA antibody production in MRL mice by treatment with anti-idiotypic antibodies.
    Mahana W; Guilbert B; Avrameas S
    Clin Exp Immunol; 1987 Dec; 70(3):538-45. PubMed ID: 3501743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The idiotypic network in the regulation of autoimmunity: Theoretical and experimental studies.
    Menshikov I; Beduleva L; Frolov M; Abisheva N; Khramova T; Stolyarova E; Fomina K
    J Theor Biol; 2015 Jun; 375():32-39. PubMed ID: 25445185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal rheumatoid factor-secreting cells in a patient with mixed cryoglobulinemia. Homogeneity and stability of the idiotypic production and in vitro idiotypic suppression.
    Pasquali JL; Martin T; Knapp AM; Levallois H; Farradji A
    J Immunol; 1989 Sep; 143(6):1826-31. PubMed ID: 2789250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiotypic networks and their possible exploitation for manipulation of the immune response.
    Roitt IM; Cooke A; Male DK; Hay FC; Guarnotta G; Lydyard PM; de Carvalho LP; Thanavala Y; Ivanyi J
    Lancet; 1981 May; 1(8228):1041-5. PubMed ID: 6164887
    [No Abstract]   [Full Text] [Related]  

  • 32. Self-nonself discrimination in the immune system. A broken idiotypic mirror.
    Urbain J; Andris F; Brait M; De Wit D; Mertens F; Willems F
    Ann N Y Acad Sci; 1988; 546():43-50. PubMed ID: 3073698
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunoregulatory role of maternal idiotypes. Ontogeny of immune networks.
    Wikler M; Demeur C; Dewasme G; Urbain J
    J Exp Med; 1980 Oct; 152(4):1024-35. PubMed ID: 6158544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-idiotypic antibodies: from regulation to therapy of factor VIII inhibitors.
    Saint-Remy JM; Jacquemin MG; Gilles JG
    Vox Sang; 1999; 77 Suppl 1():21-4. PubMed ID: 10529681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of idiotypic and anti-idiotypic antibodies as models of receptor and ligand.
    Linthicum DS; Bolger MB; Kussie PH; Albright GM; Linton TA; Combs S; Marchetti D
    Clin Chem; 1988 Sep; 34(9):1676-80. PubMed ID: 2901298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The idiotypic network: order from the beginning or order out of chaos?
    Urbain J; Brait M; Bruyns C; Demeur C; Dubois P; Francotte M; Franssen JD; Hiernaux J; Leo O; Marvel J
    Curr Top Microbiol Immunol; 1985; 119():127-42. PubMed ID: 3910361
    [No Abstract]   [Full Text] [Related]  

  • 37. Natural tolerance in a simple immune network.
    Calenbuhr V; Bersini H; Stewart J; Varela FJ
    J Theor Biol; 1995 Dec; 177(3):199-213. PubMed ID: 8746325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective suppression of the major idiotypic component of an antihapten response by soluble T cell-derived factors with idiotypic or anti-idiotypic receptors.
    Hirai Y; Nisonoff A
    J Exp Med; 1980 May; 151(5):1213-31. PubMed ID: 6966320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of collagen arthritis in rats by heterologous anti-idiotypic antisera against anticollagen antibodies.
    Arita C; Kaibara N; Jingushi S; Takagishi K; Hotokebuchi T; Arai K
    Clin Immunol Immunopathol; 1987 Jun; 43(3):374-81. PubMed ID: 3495379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of auto-anti-idiotypic antibody during the normal immune response. XII. Enhanced auto-anti-idiotypic antibody production as a mechanism for apparent B-cell tolerance in rabbits after feeding antigen.
    Bhogal BS; Karkhanis YD; Bell MK; Sanchez P; Zemcik B; Siskind GW; Thorbecke GJ
    Cell Immunol; 1986 Aug; 101(1):93-104. PubMed ID: 3091266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.